St. Jude Medical (STJ) Releases MAUDE Database; Says Six-Fold Overstatment in Number of Deaths
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ), has posted information from the MAUDE database showing 377 deaths associated with the Medtronic (Nasdaq: MDT) Quattro Secure lead, rather than the 62 that was reported by Dr. Robert Hauser in a manuscript published online last week by the Heart Rhythm Journal.
Dr. Hauser’s review of the number of deaths in the MAUDE database was wrong by greater than a factor of six.
The company has called upon Dr. Hauser to state specifically whether or not he stands behind the factual accuracy of the number 62 used in comparing the St. Jude Medical Riata® and Riata ST leads to the Medtronic Quattro Secure device. The company also invites Medtronic to review the MAUDE database report findings.
Dr. Hauser’s review of the number of deaths in the MAUDE database was wrong by greater than a factor of six.
The company has called upon Dr. Hauser to state specifically whether or not he stands behind the factual accuracy of the number 62 used in comparing the St. Jude Medical Riata® and Riata ST leads to the Medtronic Quattro Secure device. The company also invites Medtronic to review the MAUDE database report findings.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- Synaptics CFO resigns amid pending ON Semiconductor merger
- Sky Quarry names Heidi Bowman as CFO
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
